IRS Issues Guidance on New Tax Credits and Cash Grants for Small Biotech Companies

The PPACA established a tax subsidy for eligible small biotech companies known as the "qualifying therapeutic discovery project" credit. The tax subsidy consists of $1 billion of tax credits or, at the taxpayer's election, cash grants for "qualified investments" made by small biotech companies for the development of new therapies to prevent, diagnose and treat acute and chronic diseases. On May 21, 2010, the Internal Revenue Service (IRS) issued a notice establishing the program and announcing the procedures for applying for credits or cash grants.  A Reed Smith tax alert regarding the IRS guidance is available here.

Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.healthindustrywashingtonwatch.com/admin/trackback/204116
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.